Innovative polymeric system (IPS) for solvent-free lipophilic drug transdermal delivery via dissolving microneedles

Manita Dangol, Huisuk Yang, Cheng Guo Li, Shayan Fakhraei Lahiji, Suyong Kim, Yonghao Ma, Hyungil Jung

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Lipophilic drugs are potential drug candidates during drug development. However, due to the need for hazardous organic solvents for their solubilization, these drugs often fail to reach the pharmaceutical market, and in doing so highlight the importance of solvent free systems. Although transdermal drug delivery systems (TDDSs) are considered prospective safe drug delivery routes, a system involving lipophilic drugs in solvent free or powder form has not yet been described. Here, we report, for the first time, a novel approach for the delivery of every kind of lipophilic drug in powder form based on an innovative polymeric system (IPS). The phase transition of powder form of lipophilic drugs due to interior chemical bonds between drugs and biodegradable polymers and formation of nano-sized colloidal structures allowed the fabrication of dissolving microneedles (DMNs) to generate a powerful TDDS. We showed that IPS based DMN with powder capsaicin enhances the therapeutic effect for treatment of the rheumatic arthritis in a DBA/1 mouse model compared to a solvent-based system, indicating the promising potential of this new solvent-free platform for lipophilic drug delivery.

Original languageEnglish
Pages (from-to)118-125
Number of pages8
JournalJournal of Controlled Release
Volume223
DOIs
Publication statusPublished - 2016 Feb 10

Fingerprint

Pharmaceutical Preparations
Powders
Drug Delivery Systems
Inbred DBA Mouse
Rheumatic Fever
Capsaicin
Phase Transition
Therapeutic Uses
Polymers
Therapeutics

All Science Journal Classification (ASJC) codes

  • Pharmaceutical Science

Cite this

Dangol, Manita ; Yang, Huisuk ; Li, Cheng Guo ; Lahiji, Shayan Fakhraei ; Kim, Suyong ; Ma, Yonghao ; Jung, Hyungil. / Innovative polymeric system (IPS) for solvent-free lipophilic drug transdermal delivery via dissolving microneedles. In: Journal of Controlled Release. 2016 ; Vol. 223. pp. 118-125.
@article{56c2195716c643118b62a4768064264c,
title = "Innovative polymeric system (IPS) for solvent-free lipophilic drug transdermal delivery via dissolving microneedles",
abstract = "Lipophilic drugs are potential drug candidates during drug development. However, due to the need for hazardous organic solvents for their solubilization, these drugs often fail to reach the pharmaceutical market, and in doing so highlight the importance of solvent free systems. Although transdermal drug delivery systems (TDDSs) are considered prospective safe drug delivery routes, a system involving lipophilic drugs in solvent free or powder form has not yet been described. Here, we report, for the first time, a novel approach for the delivery of every kind of lipophilic drug in powder form based on an innovative polymeric system (IPS). The phase transition of powder form of lipophilic drugs due to interior chemical bonds between drugs and biodegradable polymers and formation of nano-sized colloidal structures allowed the fabrication of dissolving microneedles (DMNs) to generate a powerful TDDS. We showed that IPS based DMN with powder capsaicin enhances the therapeutic effect for treatment of the rheumatic arthritis in a DBA/1 mouse model compared to a solvent-based system, indicating the promising potential of this new solvent-free platform for lipophilic drug delivery.",
author = "Manita Dangol and Huisuk Yang and Li, {Cheng Guo} and Lahiji, {Shayan Fakhraei} and Suyong Kim and Yonghao Ma and Hyungil Jung",
year = "2016",
month = "2",
day = "10",
doi = "10.1016/j.jconrel.2015.12.038",
language = "English",
volume = "223",
pages = "118--125",
journal = "Journal of Controlled Release",
issn = "0168-3659",
publisher = "Elsevier",

}

Innovative polymeric system (IPS) for solvent-free lipophilic drug transdermal delivery via dissolving microneedles. / Dangol, Manita; Yang, Huisuk; Li, Cheng Guo; Lahiji, Shayan Fakhraei; Kim, Suyong; Ma, Yonghao; Jung, Hyungil.

In: Journal of Controlled Release, Vol. 223, 10.02.2016, p. 118-125.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Innovative polymeric system (IPS) for solvent-free lipophilic drug transdermal delivery via dissolving microneedles

AU - Dangol, Manita

AU - Yang, Huisuk

AU - Li, Cheng Guo

AU - Lahiji, Shayan Fakhraei

AU - Kim, Suyong

AU - Ma, Yonghao

AU - Jung, Hyungil

PY - 2016/2/10

Y1 - 2016/2/10

N2 - Lipophilic drugs are potential drug candidates during drug development. However, due to the need for hazardous organic solvents for their solubilization, these drugs often fail to reach the pharmaceutical market, and in doing so highlight the importance of solvent free systems. Although transdermal drug delivery systems (TDDSs) are considered prospective safe drug delivery routes, a system involving lipophilic drugs in solvent free or powder form has not yet been described. Here, we report, for the first time, a novel approach for the delivery of every kind of lipophilic drug in powder form based on an innovative polymeric system (IPS). The phase transition of powder form of lipophilic drugs due to interior chemical bonds between drugs and biodegradable polymers and formation of nano-sized colloidal structures allowed the fabrication of dissolving microneedles (DMNs) to generate a powerful TDDS. We showed that IPS based DMN with powder capsaicin enhances the therapeutic effect for treatment of the rheumatic arthritis in a DBA/1 mouse model compared to a solvent-based system, indicating the promising potential of this new solvent-free platform for lipophilic drug delivery.

AB - Lipophilic drugs are potential drug candidates during drug development. However, due to the need for hazardous organic solvents for their solubilization, these drugs often fail to reach the pharmaceutical market, and in doing so highlight the importance of solvent free systems. Although transdermal drug delivery systems (TDDSs) are considered prospective safe drug delivery routes, a system involving lipophilic drugs in solvent free or powder form has not yet been described. Here, we report, for the first time, a novel approach for the delivery of every kind of lipophilic drug in powder form based on an innovative polymeric system (IPS). The phase transition of powder form of lipophilic drugs due to interior chemical bonds between drugs and biodegradable polymers and formation of nano-sized colloidal structures allowed the fabrication of dissolving microneedles (DMNs) to generate a powerful TDDS. We showed that IPS based DMN with powder capsaicin enhances the therapeutic effect for treatment of the rheumatic arthritis in a DBA/1 mouse model compared to a solvent-based system, indicating the promising potential of this new solvent-free platform for lipophilic drug delivery.

UR - http://www.scopus.com/inward/record.url?scp=84953276562&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84953276562&partnerID=8YFLogxK

U2 - 10.1016/j.jconrel.2015.12.038

DO - 10.1016/j.jconrel.2015.12.038

M3 - Article

C2 - 26732554

AN - SCOPUS:84953276562

VL - 223

SP - 118

EP - 125

JO - Journal of Controlled Release

JF - Journal of Controlled Release

SN - 0168-3659

ER -